Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Meissner

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Blood Cancer Journal|March 12, 2013
Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutationM Sigl, S Spoerl, S Schnittger, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|September 9, 1991
[Continuous intravenous infusion versus intermittent administration of streptokinase in patients with deep venous thrombosis of the lower extremity]S Lopaciuk, A J Meissner, J M Ziemski, et al.
Regulatory Peptides|October 8, 1999
Stem cell factor influences neuro-immune interactions: the response of mast cells to pituitary adenylate cyclase activating polypeptide is altered by stem cell factorA Schmidt-Choudhury, J Meissner, J Seebeck, et al.
Gruzlica I Choroby Pluc; Tuberculosis Et Pneumonologia|August 1, 1971
[Comparison of clinical pictures in selected forms of tuberculosis in children]K Kryszkiewicz, B Czarnowska-Nastula, H Gwiazda-Pietrasz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2013
Impact of risk factors on outcomes in early-stage Hodgkin's lymphoma: an analysis of international staging definitionsB Klimm, H Goergen, M Fuchs, et al.
Journal of Internal Medicine|September 1, 2010
Interleukin family member ST2 and mortality in acute dyspnoeaT Socrates, C deFilippi, T Reichlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2015
Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphomaJ Meissner, D Tichy, V Katzke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2020
Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines<sup>†</sup>M Lambertini, F A Peccatori, I Demeestere, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitorsG D Hartman, M E Duggan, W F Hoffman, et al.
Bone Marrow Transplantation|December 20, 2016
Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experienceJ Meissner, H Finel, S Dietrich, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Blood Cancer Journal|March 12, 2013
Imatinib failure and response to dasatinib in a patient with chronic myeloid leukemia in blast crisis and a novel, nine-nucleotide BCR-ABL insertion mutationM Sigl, S Spoerl, S Schnittger, et al.
Polski Tygodnik Lekarski (Warsaw, Poland : 1960)|September 9, 1991
[Continuous intravenous infusion versus intermittent administration of streptokinase in patients with deep venous thrombosis of the lower extremity]S Lopaciuk, A J Meissner, J M Ziemski, et al.
Regulatory Peptides|October 8, 1999
Stem cell factor influences neuro-immune interactions: the response of mast cells to pituitary adenylate cyclase activating polypeptide is altered by stem cell factorA Schmidt-Choudhury, J Meissner, J Seebeck, et al.
Gruzlica I Choroby Pluc; Tuberculosis Et Pneumonologia|August 1, 1971
[Comparison of clinical pictures in selected forms of tuberculosis in children]K Kryszkiewicz, B Czarnowska-Nastula, H Gwiazda-Pietrasz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 24, 2013
Impact of risk factors on outcomes in early-stage Hodgkin's lymphoma: an analysis of international staging definitionsB Klimm, H Goergen, M Fuchs, et al.
Journal of Internal Medicine|September 1, 2010
Interleukin family member ST2 and mortality in acute dyspnoeaT Socrates, C deFilippi, T Reichlin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 13, 2015
Long-term ovarian function in women treated with CHOP or CHOP plus etoposide for aggressive lymphomaJ Meissner, D Tichy, V Katzke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 25, 2020
Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines<sup>†</sup>M Lambertini, F A Peccatori, I Demeestere, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Nonpeptide glycoprotein IIB/IIIA inhibitors. 19. A new design paradigm employing linearly minimized, centrally constrained, exosite inhibitorsG D Hartman, M E Duggan, W F Hoffman, et al.
Bone Marrow Transplantation|December 20, 2016
Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experienceJ Meissner, H Finel, S Dietrich, et al.
Pageof 12